Solution of the Riemann boundary value problem with square roots (1.1) for analytic functions proposed in [1] is reconsidered, which was solved under certain assumptions on the branch points appeared. Here the work is...Solution of the Riemann boundary value problem with square roots (1.1) for analytic functions proposed in [1] is reconsidered, which was solved under certain assumptions on the branch points appeared. Here the work is continued without these assumptions and the problem is solved in the general case.展开更多
The solution of the non-homogeneous Riemann boundary value problem with radicals (1. 2) together with its condition of solvability is obtained for arbitrary positive integersp andq, which generalizes the results for t...The solution of the non-homogeneous Riemann boundary value problem with radicals (1. 2) together with its condition of solvability is obtained for arbitrary positive integersp andq, which generalizes the results for the casep=q=2.展开更多
Human papillomavirus 18(HPV18) E6 and E7 oncogenes are transcribed as a single bicistronic E6 E7 pre-mRNA. The E6 ORF region in the bicistronic E6 E7 pre-mRNA contains an intron. Splicing of this intron disrupts the E...Human papillomavirus 18(HPV18) E6 and E7 oncogenes are transcribed as a single bicistronic E6 E7 pre-mRNA. The E6 ORF region in the bicistronic E6 E7 pre-mRNA contains an intron. Splicing of this intron disrupts the E6 ORF integrity and produces a spliced E6*I RNA for efficient E7 translation. Here we report that the E6 intron has two overlapped branch point sequences(BPS) upstream of its 30 splice site, with an identical heptamer AACUAAC, for E6*I splicing. One heptamer has a branch site adenosine(underlined) at nt 384 and the other at nt 388. E6*I splicing efficiency correlates to the expression level of E6 and E7 proteins and depends on the selection of which branch site. In general, E6*I splicing prefers the 30 ss-proximal branch site at nt 388 over the distal branch site at nt 384. Inactivation of the nt 388 branch site was found to activate a cryptic acceptor site at nt 636 for aberrant RNA splicing. Together, these data suggest that HPV18 modulates its production ratio of E6 and E7 proteins by alternative selection of the two mapped branch sites for the E6*I splicing, which could be beneficial in its productive or oncogenic infection according to the host cell environment.展开更多
基金Project supported by NNSF of China (No.19871064)
文摘Solution of the Riemann boundary value problem with square roots (1.1) for analytic functions proposed in [1] is reconsidered, which was solved under certain assumptions on the branch points appeared. Here the work is continued without these assumptions and the problem is solved in the general case.
文摘The solution of the non-homogeneous Riemann boundary value problem with radicals (1. 2) together with its condition of solvability is obtained for arbitrary positive integersp andq, which generalizes the results for the casep=q=2.
基金fully supported by Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research (1ZIASC010357 to ZMZ)a part of Brant AC Ph.D thesis being developed at the Post-graduate program in Genetics (PGGEN) of Rio de Janeiro Federal University (UFRJ), Rio de Janeiro, Brazil+2 种基金the National Cancer Institute of USAsupported by the PDSE program of Coordenacao de Aperfeicoamento de Pessoal de Nível Superior (Capes, Brazil)the National Cancer Institute of USA
文摘Human papillomavirus 18(HPV18) E6 and E7 oncogenes are transcribed as a single bicistronic E6 E7 pre-mRNA. The E6 ORF region in the bicistronic E6 E7 pre-mRNA contains an intron. Splicing of this intron disrupts the E6 ORF integrity and produces a spliced E6*I RNA for efficient E7 translation. Here we report that the E6 intron has two overlapped branch point sequences(BPS) upstream of its 30 splice site, with an identical heptamer AACUAAC, for E6*I splicing. One heptamer has a branch site adenosine(underlined) at nt 384 and the other at nt 388. E6*I splicing efficiency correlates to the expression level of E6 and E7 proteins and depends on the selection of which branch site. In general, E6*I splicing prefers the 30 ss-proximal branch site at nt 388 over the distal branch site at nt 384. Inactivation of the nt 388 branch site was found to activate a cryptic acceptor site at nt 636 for aberrant RNA splicing. Together, these data suggest that HPV18 modulates its production ratio of E6 and E7 proteins by alternative selection of the two mapped branch sites for the E6*I splicing, which could be beneficial in its productive or oncogenic infection according to the host cell environment.
